CRI awarded over $22 million to leading cancer immunotherapy researchers in the 2024 fiscal year, amounting to 64 awards at 42 institutions.
CRI awarded over $22 million to leading cancer immunotherapy researchers in the 2024 fiscal year, amounting to 64 awards at 42 institutions.